Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eucalyptus Oil as Adjuvant Therapy for COVID-19
NCT05398965Phase 2Completed
- Sponsor
- Hasanuddin University
- Start
- Nov 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eucalyptus oil in coronavirus disease 2019 (COVID-19), sponsored by Hasanuddin University. Started Nov 2020; status: completed.
02
Drugs
eucalyptus oil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05398965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398965.